Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

Share Price is delayed by 15 minutes
Get Live Data
318.80    7.00 (2.25%)
Bid:
320.80
Ask:
322.00
Spread: 1.20 (0.374%)
Market Cap: £698.39m
BUR Live PriceLast checked at - London Stock Exchange

Intraday Burford Capital Share Chart

COMPLETION OF REORGANISATION

12 Dec 2012 07:00

RNS Number : 2955T
Burford Capital
12 December 2012
Β 

ο»Ώ

12 December 2012

Β 

BURFORD CAPITAL ANNOUNCES COMPLETION OF REORGANISATION

Β 

Business poised for future growth

Β 

Β 

Burford Capital Limited (the "Company") is pleased to announce today that it has completed the Reorganisation described in the Company's announcement of 22 November 2012. The Company has issued 24,545,454 new ordinary shares of the Company (the "New Ordinary Shares") to the principals of the Investment Adviser and cancelled the investment advisory agreement that entitled the principals to performance fees. The principal's Ordinary Shares are subject to a two-year lock-up, and the principals are subject to other restrictions and constraints negotiated with the Company's Board.

Β 

An application has been made for the New Ordinary Shares, which will rank pari passu with the Company's existing Ordinary Shares, to be admitted to trading on AIM and trading in such shares is expected to commence today, 12 December 2012.

Β 

Following the issue of the New Ordinary Shares, the total number of shares in issue and the total number of Ordinary Shares in the Company with voting rights will be 204,545,455. This figure may be used by shareholders in the Company as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change of interest in, the share capital of the Company under the Financial Service Authority's Disclosure and Transparency Rules.

For further information, please contact:

Β 

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

Steve Baldwin +44 (0)20 3037 2000

Nicholas Harland

Β 

Espirito Santo Investment Bank - Joint Broker

Richard Crawley +44 (0)20 7456 9191

Β 

RBC Capital Markets - Joint Broker

Oliver Hearsey +44 (0) 20 7653 4000

James Kelly

Β 

FTI Consulting - PR for Burford Capital

Edward Berry +44 (0)20 7269 7297

Laura Ewart +44 (0)20 7269 7243

Β 

About Burford

Β 

Burford is the world's largest provider of investment capital and risk solutions for litigation.

Β 

Burford Capital is a closed-end $300 million investment fund publicly traded on the London Stock Exchange's AIM Market under the ticker symbol BUR. Burford provides a broad range of corporate finance solutions to lawyers and clients engaged in significant litigation and arbitration around the world and has an expert team drawn from major law firms and corporations.

Β 

For more information about Burford: www.burfordcapital.com.

Β 

Macquarie Capital (Europe) Limited ("Macquarie"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for the Company and no-one else in connection with the Acquisition and will not be responsible to anyone other than the Company for providing the protections afforded to customers of Macquarie or for providing advice in relation to the Acquisition.

Β 

This document does not constitute an offer of securities for sale in the United States or in any other jurisdiction. The securities mentioned in this document may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended. There is no intention to register securities, or any offering or placement thereof, in the United States or to conduct a public offering of securities in the United States. The Company has not been registered under the United States Investment Company Act of 1940, as amended.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCFFUFMFFESEIE
Date   Source Headline
25th Jun 202611:00 amRNSIssue of Equity in Connection with NED Plan Grants
17th Jun 202612:00 pmRNSDirector/PDMR Shareholding & Equity Issue re DCP
29th May 20262:00 pmRNSSterling FX Rate for 2025 Final Dividend
21st May 202612:00 pmRNSNotice of Retail Shareholder Audio Webcast
14th May 202612:00 pmRNSResult of AGM
8th May 202612:00 pmRNS1Q26 Financial Results
5th May 202612:00 pmRNSNotice of 1Q26 Results & Results Call Details
7th Apr 20267:00 amRNSHolding(s) in Company
31st Mar 20267:00 amRNSDirector/PDMR Shareholding & Issue of Equity
30th Mar 20267:00 amRNSBurford Capital Further Statement on YPF
30th Mar 20267:00 amRNSBurford Capital Statement Re YPF Appeal Decision
27th Mar 20263:32 pmRNSBurford Capital Statement re YPF Matter
17th Mar 202612:00 pmRNSCompletion of Share Repurchase Program
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
9th Mar 20261:45 pmRNSSubstantial Share Purchases by Executive Officers
26th Feb 20261:00 pmRNSAnnual Results for Year Ended December 31, 2025
10th Feb 20261:00 pmRNSNotice of 2025 Results & Results Call Details
27th Jan 20261:30 pmRNSPricing of Early Redemption of Bonds Due 2026
15th Jan 20263:41 pmRNSNotice of Early Redemption of Bonds Due 2026
15th Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSPricing and Upsizing of Senior Notes Offering
12th Jan 20262:01 pmRNSPrivate Offering of Senior Notes
5th Jan 20261:00 pmRNSIssue of New Shares in Connection with LTIP
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
4th Dec 20251:00 pmRNSDirector/PDMR Shareholding
7th Nov 20251:00 pmRNSSterling Conversion Rate for 2025 Interim Dividend
6th Nov 20257:00 amRNSHolding(s) in Company
5th Nov 20251:00 pmRNSAppointment of Joint Corporate Broker
5th Nov 20251:00 pmRNS3Q25 and YTD25 Financial Results
29th Oct 20257:00 amRNSHolding(s) in Company
24th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20251:00 pmRNSNotice of 3Q25 Results & Results Call Details
22nd Oct 20251:00 pmRNSYPF Matter Update
10th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding & New Share Issuance
1st Oct 20252:00 pmRNSHolding(s) in Company
29th Sep 20251:00 pmRNSInterim Dividend Declaration
29th Sep 20257:00 amRNSHolding(s) in Company
23rd Sep 20259:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSDirector/PDMR Shareholding
7th Aug 20251:00 pmRNS2Q25 and YTD25 Financial Results
24th Jul 202512:00 pmRNSNotice of 2Q25 Results & Results Call Details
14th Jul 202512:00 pmRNSClosing of Private Offering of Senior Notes
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
8th Jul 20255:21 pmRNSPricing and Upsizing of Senior Notes Offering
7th Jul 202512:57 pmRNSPrivate Offering of Senior Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.